University Hospital Southampton (UHS) NHS Foundation Trust has signed a commercial collaboration agreement with Automata to develop new applications for laboratory automation technology. Automata is a London based biotech company providing robotic automation solutions to the life sciences industry. Comprising proprietary hardware, single-platform software and a world-class service, Automata partners with labs to take the hassle out of automation, empowering them to achieve more reliable results faster than ever before....

Global Access Health (GAH), a social enterprise dedicated to providing affordable medical products for global health, today formally introduced its first portfolio company, Global Access Diagnostics (GADx). GADx has been created to address gaps in the global provision of diagnostics with a focus on expanding affordable access to quality tests. The Company combines expertise in rapid diagnostics development from Mologic Ltd with low-cost manufacturing and scale-up capability of sister company, Global Access Diagnostics (GAD)...

Ziath has published a new catalogue that provides an informative technical introduction to its extensive range of innovative readers, scanners, software, automated tube selectors and accessories for tracking and management of life science samples. Over the last two decades, Ziath has established itself as a global leader for sample tracking of 2D barcoded tubes in applications including biobanking. compound management and COVID-19 patient sample management....

Matrix Diagnostics – a dedicated COVID-19 testing lab in California – is relying on INTEGRA Biosciences’ EVOLVE and MINI 96 pipettes to streamline and accelerate its PCR workflows. Founded in January 2021 to meet the growing demand for testing in the San Francisco Bay Area, Matrix Diagnostics is using these user-friendly and cost-effective solutions to test up to 5000 samples a day...

Merck, a leading science and technology company, has signed an agreement with the Administrative Management Committee of Wuxi National High-Tech Industrial Development Zone to significantly expand Merck’s first Asia-Pacific Mobius® Single-Use manufacturing center in China. For more than two decades, Merck’s Life Science business sector...

A partnership between antibody development experts and global healthcare providers creates a new COVID-19 treatment for immunocompromised, high-risk, and vaccine refractory individuals, effective against major variants including Omicron. ProteoGenix(market-leading antibody provider), Aseem Healthcare (global healthcare company), and Trident Biopharm Solutions (life science consultancy agency)...

Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other diseases, and Mologic, Ltd. (Mologic), part of the recently formed social enterprise Global Access Health and a leading developer of lateral flow and rapid diagnostic tests (RDTs), has announced a collaboration to utilize Alamar’s novel antibodies against SARS-CoV-2 Nucleocapsid (N) protein for Mologic’s future COVID-19 RDTs.

Merck, a leading science and technology company, is expanding its membrane and filtration manufacturing capabilities in Ireland. The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland. The investment, which is the largest in a single site ever for Merck’s Life Science business sector, will create more than 370 permanent jobs by the end of 2027...

Since the start of the pandemic, a surge in sampling demand is putting ​laboratories under pressure, driving up the market, especially in labs that do qPCR and PCR applications. Automated liquid handling platforms, like PIPETMAX®, automate most of the liquid handling steps in your assays, increasing throughput and establishing a robust method for your laboratory workflow. Read our article "The benefits of adding robotics to your lab" to discover the major benefits of adopting automated pipetting systems into your liquid handling workflow...

PrecisionLife Limited, a global techbio company using its deep insights into disease biology and patient stratification to drive precision medicine in chronic diseases, is pleased to announce a partnership with Sano Genetics, a genetic research platform enabling patients to participate in ethical research projects, to advance understanding of the long-term effects of coronavirus infection (long COVID)...

Autoscribe Informatics has announced that Covid-19 Test Laboratory, BioGrad Diagnostics, has adopted Matrix Gemini as its Laboratory Information Management System (LIMS). BioGrad manages client and sample data within the LIMS, driving automation and efficiency. BioGrad Diagnostics is a rapidly expanding diagnostics laboratory in the UK focused on fast turn-around COVID-19 samples....

The Chromatrap® Homogeniser Spin Column from Porvair Sciences maximises the yield and quality of viral RNA extracted from nasal and throat swab samples. The easy-to-use spin column offers a fast and efficient ‘one-stop’ alternative to using traditional syringe and needle homogenisation techniques. Employing a novel dual frit extraction design the Chromatrap® Homogeniser Spin Column reduces lysate viscosity and captures insoluble debris by centrifugation....

MolGen introduces a new RT-qPCR multiplex kit that combines the detection of five different infectious respiratory viruses, including SARS-CoV-2. The MolGen MoaA RT-q kit is a single well, multiplex RT-qPCR which targets: Influenza A virus, Influenza B virus, Respiratory syncytial viruses (RSV) type A & type B and SARS-CoV-2. These 5 targets represent the most common respiratory threats of this moment...

INTEGRA Biosciences’ VOYAGER adjustable tip spacing pipettes and EVOLVE manual pipettes are playing pivotal roles in COVID-19 testing at Children’s Minnesota, an award-winning, non-profit acute pediatric healthcare group in the ‘twin cities’ of Saint Paul and Minneapolis. These innovative tools have helped the group’s molecular laboratory to process more samples, more effectively in this unpredictable sociomedical period....

The rapid spread of SARS-CoV-2 has heavily impacted global society with high pressure of COVID-19 on public health and economics. MolGen is very proud to have assisted in relieving some of the pressure and support the testing framework. Our high-quality nucleic acid extraction kits provide laboratories worldwide with innovative solution for efficient high throughput testing possibilities...

Software which helps speed up the process of creating new diagnostic tests could help combat future pandemics, its developers say. A team of bioengineers and chemists in Scotland and China have developed a system which suggests new reaction pathways to accelerate the design and development of new diagnostic assays. The system, which is now freely available for other researchers around the world to investigate, adapt and use, can also be used to identify the early stages of non-infectious diseases...

TestRAMP, the UK marketplace for Covid-19 PCR testing, is launching a new service for genomic testing and profiling of other diseases. Mike Hudson, CEO, said “We want to put the experience of working with the UK’s top genetic and genomic laboratories to good use. Covid testing grew the capacity and expertise of PCR and genomic sequencing labs – now they are well placed to offer molecular testing for other serious diseases”...

Biotool Switzerland has added a new version of its TubeFiller automated bottle / tube filling system to their range of easy-to-use, productivity enhancing sample handling and sample preparation equipment. The TubeFiller TF 3000x is a versatile system proven to deliver true walkaway filling of tubes, well plates or bottles in any standard rack format. The TubeFiller is not only versatile but is the only automated filling instrument on the market capable of filling up to 2000 tubes or bottles per hour with good reproducibility, making it perfect for COVID-19 testing labs...

The surge in demand brought about by COVID-19 is pushing medical and non-medical laboratories to their limits, the head of a laboratory supplies company has said, with concerns that clinical laboratories have been favoured due to the pandemic. The Starlab Group, a European supplier of laboratory products with a UK division, conducted a survey of more than 200 laboratory employees from the UK, Germany, Austria, Italy and France...